MedTrace Logo

Preeclampsia Subtypes and Surrogate Markers of CVD Risk

NCT02337049 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2015-01-13

No results posted yet for this study

Summary

In order to assess surrogate markers of cardiovascular risk in subtypes of preeclampsia, we will conduct a 10-year follow-up study comparing 40 women with a history of early onset preeclampsia; 40 women with a history of late onset preeclampsia and 40 women with a history of normotensive pregnancies.

Eligible participants delivered at the Department of Obstetrics at Randers Regional Hospital 1998-2008.

Early-onset preeclampsia is defined as preeclampsia that develops before 34 weeks of gestation, whereas late-onset preeclampsia develops at or after 34 weeks of gestation.

Conditions

Sponsors & Collaborators

  • Randers Regional Hospital

    collaborator OTHER

  • Karen Elise Jensen Foundation

    collaborator OTHER

  • Central Denmark Region

    collaborator OTHER

  • University of Aarhus

    lead OTHER

Principal Investigators

  • Ulla B Knudsen, Professor · Department of Obstetrics and Gynaecology, Aarhus University Hos

  • Martin Christensen, MD · Clinical Research Unit, Randers Regional Hospital

  • Camilla S Kronborg, MD, PhD · Department of Oncology, Aarhus University Hospital

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2015-12-31
Completion
2016-04-30

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02337049 on ClinicalTrials.gov